PROCEPT BioRobotics (PRCT) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -54.17% |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | -31.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.49% |
| Mar 31, 2026 | -133.01% |
| Dec 31, 2025 | -105.65% |
| Sep 30, 2025 | 51.38% |
| Jun 30, 2025 | -17.28% |
| Mar 31, 2025 | 44.64% |
| Dec 31, 2024 | 546.98% |
| Sep 30, 2024 | -112.61% |
| Jun 30, 2024 | 63.29% |
| Mar 31, 2024 | 22.60% |
| Dec 31, 2023 | -12.00% |
| Sep 30, 2023 | 767.36% |
| Jun 30, 2023 | -116.00% |
| Mar 31, 2023 | -140.58% |
| Dec 31, 2022 | -69.25% |
| Sep 30, 2022 | -112.77% |
| Jun 30, 2022 | -119.81% |
| Mar 31, 2022 | -21.29% |
| Dec 31, 2021 | -22.30% |